November 23, 2016 - By Vivian Park · 0 Comments
The stock of Amerisourcebergen Corporation (NYSE:ABC) registered a decrease of 1.23% in short interest. ABC’s total short interest was 20.06 million shares in November as published by FINRA. Its down 1.23% from 20.31M shares, reported previously. With 2.75 million shares average volume, it will take short sellers 7 days to cover their ABC’s short positions. The short interest to Amerisourcebergen Corporation’s float is 12.32%. The stock decreased 0.05% or $0.04 during the last trading session, hitting $78.41. AmerisourceBergen Corp. (NYSE:ABC) has declined 14.61% since April 21, 2016 and is downtrending. It has underperformed by 19.94% the S&P500.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The company has a market cap of $18.47 billion. The Company’s divisions include Pharmaceutical Distribution and Other. It has a 12.37 P/E ratio. The Firm provides services to healthcare providers, and pharmaceutical and biotech manufacturers.
Out of 15 analysts covering AmerisourceBergen (NYSE:ABC), 7 rate it a “Buy”, 0 “Sell”, while 8 “Hold”. This means 47% are positive. $130 is the highest target while $83 is the lowest. The $99.23 average target is 26.55% above today’s ($78.41) stock price. AmerisourceBergen has been the topic of 30 analyst reports since July 27, 2015 according to StockzIntelligence Inc. Mizuho maintained the stock with “Neutral” rating in Thursday, August 11 report. The firm has “Market Perform” rating given on Wednesday, January 6 by Raymond James. On Wednesday, October 7 the stock rating was maintained by RBC Capital Markets with “Outperform”. FBR Capital maintained AmerisourceBergen Corp. (NYSE:ABC) rating on Friday, May 6. FBR Capital has “Mkt Perform” rating and $84 price target. FBR Capital maintained AmerisourceBergen Corp. (NYSE:ABC) on Thursday, February 4 with “Mkt Perform” rating. As per Thursday, October 6, the company rating was initiated by UBS. The stock of AmerisourceBergen Corp. (NYSE:ABC) has “Outperform” rating given on Friday, May 6 by RBC Capital Markets. Mizuho maintained AmerisourceBergen Corp. (NYSE:ABC) rating on Wednesday, November 18. Mizuho has “Neutral” rating and $105 price target. As per Friday, October 2, the company rating was downgraded by Morgan Stanley. The stock has “Buy” rating given by TheStreet on Monday, July 27.
AmerisourceBergen Corporation, incorporated on March 16, 2001, is a pharmaceutical sourcing and distribution services company. The Company’s divisions include Pharmaceutical Distribution and Other. The Firm provides services to healthcare providers, and pharmaceutical and biotech manufacturers.
More news for AmerisourceBergen Corp. (NYSE:ABC) were recently published by: Wsj.com, which released: “AmerisourceBergen Reports Revenue Growth” on November 02, 2016. Forbes.com‘s article titled: “Ex-Dividend Reminder: AmerisourceBergen, Radian Group and Symantec” and published on November 15, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park